Cirrhotic Cardiomyopathy
Cirrhotic cardiomyopathy (CCM), cardiac dysfunction in end-stage liver disease in the absence of prior heart disease, is an important clinical entity that contributes significantly to morbidity and mortality. The original definition for CCM, established in 2005 at the World Congress of Gastroenterol...
Main Authors: | Kieran Longley, Tuan Tran, Vincent Ho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Gastroenterology Insights |
Subjects: | |
Online Access: | https://www.mdpi.com/2036-7422/12/1/8 |
Similar Items
-
Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy
by: Hongqun Liu, et al.
Published: (2023-07-01) -
The Contemporary Role of Speckle Tracking Echocardiography in Cirrhotic Cardiomyopathy
by: Yannis Dimitroglou, et al.
Published: (2024-01-01) -
QT Interval Prolongation in Cirrhotic Cardiomyopathy
by: Tadelle A
Published: (2022-07-01) -
The diagnostic and prognostic value of serum endocan in patients with cirrhotic cardiomyopathy
by: Voiosu Andrei Mihai, et al.
Published: (2018-09-01) -
Cirrhotic cardiomyopathy and liver transplantation
by: Yu. O. Malinovskaya, et al.
Published: (2016-09-01)